Maha M Abdel-Fattah

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Benign Prostatic Hyperplasia

Nitric Oxide Synthase

Lower Urinary Tract Symptoms

Epidermal Growth Factor Receptor

Top Venues

Inflammopharmacology

Fundamental & clinical pharmacology

Journal of biochemical and molecular toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Maha M Abdel-Fattah, Ahmed Mamdouh Ahmed, Rabeh Khairy Saleh, Basim Anwar Shehata Messiha, Remon Roshdy Rofaeil
The protective effect of pregabalin and xanthenone on testicular ischemia/reperfusion injury in rats. Fundamental & clinical pharmacology (2024)
Maha M Abdel-Fattah, Mohammed E Abo-El Fetoh, Hassan Afify, Laila A A Ramadan, Wafaa R Mohamed
Probenecid ameliorates testosterone-induced benign prostatic hyperplasia: Implications of PGE-2 on ADAM-17/EGFR/ERK1/2 signaling cascade. Journal of biochemical and molecular toxicology (2023)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)